Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27000303 | 0.83 | FDPS (0.36) | MCL1FDPSLMNA | |
| SCHEMBL19570405 | 0.81 | MCL1 (0.31) | MCL1LMNAHDAC1HDAC6 | |
| SCHEMBL24926358 | 0.78 | POLB (0.42) | LMNA | |
| SCHEMBL868741 | 0.75 | ADRA2A (0.39) | PGRADRA2AADRA2BHTR2AHRH1 | |
| SCHEMBL27294800 | 0.75 | ALDH1A1 (0.36) | PGRADRA2AADRA2BHTR2AHRH1 | |
| SCHEMBL3563819 | 0.74 | TSHR (0.39) | PGRADRA2AADRA2BHTR2AHRH1 | |
| SCHEMBL4346261 | 0.73 | FDPS (0.34) | PGRADRA2AADRA2BHTR2AHRH1 | |
| SCHEMBL19361696 | 0.73 | FDPS (0.34) | PGRADRA2AADRA2BHTR2AHRH1 | |
| SCHEMBL13140797 | 0.73 | POLB (0.35) | CHRNB2CHRNA4MCL1LMNAHDAC1 | |
| SCHEMBL14336264 | 0.73 | MCL1 (0.34) | CHRNB2CHRNA4MCL1LMNAHDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170146549-A1 | ISOBARIC MASS LABELS | ELECTROPHORETICS LIMITED (GB) | 2017-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170146549-A1 | ISOBARIC MASS LABELS | SRMS, PTMS, QPCTL | CHRNB2 2955/4885CHRNA4 3662/4885PGR 3754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.